Yuan Tian | Genomics Award | Best Researcher Award

Posted on by ScienceFather

Mr. Yuan Tian | Genomics Award | Best Researcher Award

Mr. Yuan Tian, The third affiliated hospital of Zhengzhou University, China

Yuan Tian, a Chief Technician with a Master’s in Medical Science, specializes in genetic diagnostics and research. With extensive experience at Zhengzhou University’s Third Affiliated Hospital, he focuses on prenatal testing and whole exome sequencing analysis. Noteworthy contributions include papers on genetic disorders like spinal muscular atrophy and deafness. Yuan led projects funded by Henan Province Medical Science, earning awards for his research excellence. Passionate about preventing birth defects, he actively promotes key technologies in maternal and child health care. His dedication to advancing genetic diagnostics embodies a commitment to improving healthcare 🧬.

 

Publication Profile

Scopus

🎓 Education and Work Experience

Yuan Tian, a male Chief Technician, holds a Master’s Degree in Medical Science. He commenced his career in the Laboratory Department of the Third Affiliated Hospital of Zhengzhou University in 2015, specializing in molecular genetics. Over the years, he transitioned through various roles, focusing on prenatal testing and genetic analysis. Currently, he contributes to the Endocrinology and Immunology Laboratories at the same institution.

🏆 Awards and Recognition

Tian’s contributions have earned him accolades such as the third prize in the Science and Technology Achievement Award of Maternal and Child Health Care. His papers have been recognized for excellence in conferences and seminars, reflecting his dedication to advancing genetic diagnostics and healthcare.

 

Research focus

Yuan Tian’s research spans various categories within genetics and molecular biology, with a particular focus on understanding genetic causes of neurological and developmental disorders. His work delves into the intricate relationships between gene mutations and conditions such as spinal muscular atrophy, lissencephaly, and CHIME syndrome. Through systematic reviews, variant analyses, and exploration of allele frequencies, Tian contributes significantly to identifying pathogenic variants and understanding their implications. His dedication to unraveling the genetic basis of complex disorders reflects a commitment to improving diagnostic and therapeutic approaches in healthcare 🧬.

 

Publication Top Notes

📚 Tian, Y. et al. (2023). “Comparative analysis of allele frequencies of 15 deafness gene variants between hearing-loss and normal populations in Henan, China” published in Heliyon.

📅 Year: 2023

📚 Guo, J. et al. (2023). “Analysis of ARX gene variant in a child with X-linked lissencephaly with abnormal genitalia” in Chinese Journal of Medical Genetics.

📅 Year: 2023

📚 Tian, Y. et al. (2023). “Exploring the relationship between IGHMBP2 gene mutations and spinal muscular atrophy with respiratory distress type 1 and Charcot-Marie-Tooth disease type 2S: a systematic review” in Frontiers in Neuroscience.

🔗 Cited by: 1 📅 Year: 2023

📚 Tian, Y. et al. (2022). “Analysis of gene mutations of medium-chain acyl-coenzyme a dehydrogenase deficiency (MCADD) by next-generation sequencing in Henan, China” in Clinica Chimica Acta.

🔗 Cited by: 3 📅 Year: 2022

📚 Li, X. et al. (2021). “Newborn screening, gene variation analysis and follow-up study of very long chain acyl CoA dehydrogenase deficiency” in Chinese Journal of Applied Clinical Pediatrics.

🔗 Cited by: 1 📅 Year: 2021

📚 Zhang, L. et al. (2020). “Pathogenic variants identified by whole-exome sequencing in 43 patients with epilepsy” in Human Genomics.

🔗 Cited by: 7 📅 Year: 2020

📚 Guan, J. et al. (2020). “Case of CHIME syndrome and literature review” in Chinese Journal of Applied Clinical Pediatrics.

📅 Year: 2020

📚 Zhao, D. et al. (2020). “Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS)” in Journal of Pediatric Endocrinology and Metabolism.

🔗 Cited by: 5 📅 Year: 2020

📚 Tian, Y. et al. (2020). “Variant analysis of PEX11B gene from a family with peroxisome biogenesis disorder 14B by whole exome sequencing” in Molecular Genetics and Genomic Medicine.

🔗 Cited by: 12 📅 Year: 2020

📚 Tian, Y. et al. (2019). “A case of maternal 45, X/46, XX mosaicism detected by non-invasive prenatal testing” in Chinese Journal of Medical Genetics.

🔗 Cited by: 3 📅 Year: 2019

 

Chenxia Juan | Gene transcriptional regulation | Best Researcher Award

Posted on by ScienceFather

Dr. Chenxia Juan | Gene transcriptional regulation | Best Researcher Award

👩‍⚕️ Dr. Chenxia Juan is a distinguished researcher with a rich academic journey in gene transcriptional regulation. 🧬 From completing a seven-year master’s program in Clinical Medicine at Shandong University’s School of Medicine to earning a Doctor of Medicine from Nanjing Medical University, her expertise spans over a decade. 🏥 Dr. Juan’s contributions to nephrology were significant during her tenure at the Institute of Kidney Disease and the Provincial Hospital of Jiangsu Province. 🌐 She currently serves as an Associate Chief Physician at the Affiliated Hospital of Nanjing University of Chinese Medicine, coupled with a role as a Lecturer at Nanjing University of Chinese Medicine. 🎓 Her outstanding work has been recognized through prestigious awards and grants, including the National Natural Science Foundation of China. 🏆💼

Profile:

Scopus

Education:

👩‍⚕️ Dr. Chenxia Juan embarked on her academic journey at the School of Medicine, Shandong University, earning a seven-year master’s in Clinical Medicine from 2002 to 2009. 🎓 Her expertise in medicine expanded during her tenure at the Institute of Kidney Disease, Eastern Theater Command General Hospital (formerly Nanjing Military Region General Hospital) from July 2009 to October 2012. 💼 Specializing in nephrology, she played a vital role in healthcare. 🏥 Dr. Juan’s dedication to medical research and patient care during these formative years laid the foundation for her impactful contributions in the field. 🔬💉

Experience:

🏥 Dr. Chenxia Juan continued her impactful journey in nephrology, serving at the Department of Nephrology, Provincial Hospital of Jiangsu Province from January 2013 to August 2016. 🌐 Her commitment to advancing medical knowledge led her to pursue a Doctor of Medicine at Nanjing Medical University from September 2016 to June 2019. 🎓 Dr. Juan further diversified her expertise, contributing to children’s mental health research at the Brain Hospital affiliated with Nanjing Medical University. 🧠💡 Currently, she holds the esteemed position of Associate Chief Physician at the Affiliated Hospital of Nanjing University of Chinese Medicine, concurrently serving as a Lecturer at Nanjing University of Chinese Medicine since January 2021. 👩‍⚕️👩‍🏫

Scientific Research Project:

🏆 Dr. Chenxia Juan’s illustrious career is adorned with prestigious recognitions, showcasing her outstanding contributions to medical research. In 2021, she received support from the National Natural Science Foundation of China, highlighting her impactful work. 🇨🇳 The 2020 Nanjing Special Fund for Health Science and Technology Development further acknowledges her commitment to advancing healthcare in the region. 💉 Dr. Juan’s research excellence was previously recognized in 2019 by the National Natural Science Foundation of China and in 2017 through the Jiangsu Graduate Research and Practice Innovation Program Project. 🎓 Her early achievements include participation in the “Six Talent Peaks” project in Jiangsu Province in 2013, marking the beginning of her impactful research journey. 🌟

Publication:

  • “Inhibition of IGF2BP1 Attenuates Renal Injury and Inflammation by Alleviating m6A Modifications and E2F1/MIF Pathway”
    • Year: 2023
    • Authors: Mao, Y., Jiang, F., Xu, X.-J., …, Juan, C.-X., Zhou, G.-P.
    • Journal: International Journal of Biological Sciences
    • Citations: 7
    • 📖🔬
  • “Computational Detection of a Genome Instability-Derived lncRNA Signature for Predicting the Clinical Outcome of Lung Adenocarcinoma”
    • Year: 2022
    • Authors: Guo, C.-R., Mao, Y., Jiang, F., …, Zhou, G.-P., Li, N.
    • Journal: Cancer Medicine
    • Citations: 14
    • 📖🔬
  • “Knocking Down ETS Proto-oncogene 1 (ETS1) Alleviates the Pyroptosis of Renal Tubular Epithelial Cells in Patients with Acute Kidney Injury by Regulating the NLR Family Pyrin Domain Containing 3 (NLRP3) Transcription”
    • Year: 2022
    • Authors: Juan, C., Zhu, Y., Chen, Y., …, Wang, X., Wang, Q.
    • Journal: Bioengineered
    • Citations: 3
    • 📖🔬
  • “Exosome-Mediated Pyroptosis of miR-93-TXNIP-NLRP3 Leads to Functional Difference Between M1 and M2 Macrophages in Sepsis-Induced Acute Kidney Injury”
    • Year: 2021
    • Authors: Juan, C.-X., Mao, Y., Cao, Q., …, Zhou, G.-P., Jin, R.
    • Journal: Journal of Cellular and Molecular Medicine
    • Citations: 49
    • 📖🔬
  • “Long Non-Coding RNA MALAT1 Targeting STING Transcription Promotes Bronchopulmonary Dysplasia Through Regulation of CREB”
    • Year: 2020
    • Authors: Chen, J.-H., Feng, D.-D., Chen, Y.-F., …, Liu, S., Zhou, G.-P.
    • Journal: Journal of Cellular and Molecular Medicine
    • Citations: 15
    • 📖🔬
  • “Identification of Novel lncRNAs Involved in the Pathogenesis of Childhood Acute Lymphoblastic Leukemia”
    • Year: 2019
    • Authors: Li, S., Bian, H., Cao, Y., …, Zhou, G., Fang, Y.
    • Journal: Oncology Letters
    • Citations: 17
    • 📖🔬
  • “MicroRNA 34b Inhibits Cell Proliferation in Pediatric Acute Myeloid Leukemia via Regulating LDHA”
    • Year: 2019
    • Authors: Qi, H.-X., Cao, Q., Zhou, G.-P., …, Li, S., Kuai, W.-X.
    • Journal: European Review for Medical and Pharmacological Sciences
    • Citations: 2
    • 📖🔬
  • “Attenuating the Abnormally High Expression of AEBP1 Suppresses the Pathogenesis of Childhood Acute Lymphoblastic Leukemia via p53-Dependent Signaling Pathway”
    • Year: 2019
    • Authors: Li, S., Juan, C.-X., Feng, A.-M., …, Cao, Q., Zhou, G.-P.
    • Journal: European Review for Medical and Pharmacological Sciences
    • Citations: 6
    • 📖🔬
  • “Knockdown of LncRNA MALAT1 Contributes to Cell Apoptosis via Regulating NF-κB/CD80 Axis in Neonatal Respiratory Distress Syndrome”
    • Year: 2018
    • Authors: Juan, C., Wang, Q., Mao, Y., …, Zhang, D., Zhou, G.
    • Journal: International Journal of Biochemistry and Cell Biology
    • Citations: 16
    • 📖🔬